Tag: pharmaceuticals
NICE recommends Epidyolex for treatment of tuberous sclerosis complex
Portuguese Meducal Cannabis Company VF1883 Pharmaceuticals Declared Insolvent
Two More Studies Show Patients Are Replacing Prescription Painkillers With Marijuana
North America Legal Cannabis Market Report 2022: Featuring 22nd Century, Medical Marijuana Inc, Arena Pharmaceuticals & More – ResearchAndMarkets.com
UK-based Celadon Pharmaceuticals PLC received the green light to produce high-THC medicinal cannabis in its Midlands facility
Virpax Pharmaceuticals to Utilize Dr. Neil K. Singla to Assist in Development of Probudur™
Psychedelics Market Expected To Hit Approx. $12 Billion by 2029
Celadon Pharmaceuticals Shares Rise After UK Quality Standard Registration
USA | Even without proof, CBD is finding a niche as a cure-all
JAMAICA | Cannabis class at UWI Jamaica campus today
Virpax Pharmaceuticals Engages Destum Partners to Direct Strategic Global Partnering Efforts
Pain Patients Are Switching To Medical Marijuana Instead Of Opioids, American Medical Association Study Shows
Utah Group Aims To Legalize Shrooms in the State
Lawsuit: Generic drugmakers infringed on Epidiolex cannabis drug patents
Anebulo Pharmaceuticals Announces Completion of Dosing and Preliminary Data from Part B of its Phase 2 Study of ANEB-001 for Acute Cannabinoid Intoxication
Pharma Company Behind FDA-Approved CBD Drug Sues A Dozen Competitors Over Alleged Patent Infringement
Virpax Pharmaceuticals Engages Dr. Kenneth W. Sommerville and Dr. Lawrence Fried to Assist in Development of NobrXiol™ (formerly VRP324)
Google Updates Policy To Allow Hemp, CBD Products with Certification
This high-tech, grow-it-yourself medical cannabis kit is as easy as using an app
Google Ends Ban On Advertising Certain Hemp And CBD Products In Parts Of U.S.
Singapore: ‘Scientific evidence’ to guide cannabis law
Cannabis An Alternative Treatment to Pharmaceuticals .Check out this video
Colorado to allow CBD prescriptions.
A Marijuana Market Most Investors Aren’t Thinking About — The Motley Fool
Virpax Pharmaceuticals Reports on FDA Pre-IND Response for NobrXiol™ (formerly VRP324)
A Look At The Cannabis Movement In The UK
Global Industrial Hemp Market Report 2022: Growing Use of Hemp Seed and Hemp Seed Oil in Food Applications Fuels Sector – ResearchAndMarkets.com
Fentanyl Overdose Reversal Drug Stronger Than Narcan Released
ADDING MULTIMEDIA MyMD Pharmaceuticals® to Present Data on Oral TNF-a Inhibitor MYMD-1® at the British Society for Immunology (BSI) Congress 2022
TerrAscend Appoints Seasoned Finance Professional to Board
Marinus Pharmaceuticals Announces Presentations and Investor Event at American Epilepsy Society 2022 Annual Meeting
Jazz Pharma to present new research findings on Epidyolex
Royal Emerald Pharmaceuticals Partners with BioHarvest Sciences to Supply Disruptive Cannabis Solutions to Companies Conducting FDA-Approved Medical Research
Family left ‘reeling’ after NHS neurologist turns their back on cannabis patient
MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1® in Peer-Reviewed Journal Drug Research
Another Medical Cannabis Clinical Trial Launches in South Africa
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2023 Financial Results and Recent Updates
Global Cannabis Pharmaceuticals Market (2022 to 2027) – Featuring AbbVie, Amyris, Aurora Cannabis and Botanix Pharmaceuticals Among Others – ResearchAndMarkets.com
Virpax Pharmaceuticals Reports 2022 Third Quarter Results
Longboard Pharmaceuticals to Present at Guggenheim’s Healthcare Talks 4th Annual Immunology and Neurology Day
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results
Anebulo Pharmaceuticals Announces Appointment of Nat Calloway, Ph.D., to Board of Directors
Survey reveals broad spectrum of issues facing UK cannabis patients
Global Medical Marijuana Market Forecast to 2028 – Featuring Aphria, Canopy Growth, CanaQuest Medical and GW Pharmaceuticals Among Others – ResearchAndMarkets.com
Flora Growth to Acquire Pharmaceutical, Medical Cannabis Distributor in Germany
Study To Examine Why Shrooms Evolved with Psychedelic Properties
Washington State Liquor and Cannabis Board Seeks Members for Cannabinoid Science Work Group
New Research Exploring DMT as a Treatment for Stroke
Welsh campaigners to help educate doctors on medical cannabis
Press Release: Biomind Labs and Queen’s University of Belfast Receive Controlled Substances License to Commence the Production of a Novel Transdermal Drug Delivery System
Educated Stoner
Japanese Health Officials Propose Revision of Law To Allow Import, Medical Cannabis
Three Major Australian Medical Cannabis Companies Fined By The TGA “over claims prescriptions could treat conditions such as cancer and epilepsy”
Controlled Release Cannabis Pill Global Market Insights 2022: Analysis and Forecast to 2027 by Manufacturers, Regions, Technology, Application, Product Type – ResearchAndMarkets.com
Medical Marijuana Helps Patients Reduce Use Of Addictive Opioid Painkillers, Study Finds
Anebulo Pharmaceuticals Announces $6.6 Million Private Placement Financing
Anebulo Pharmaceuticals Announces Positive Interim Data for ANEB-001 from Part B of its Phase 2 Clinical Trial for Acute Cannabinoid Intoxication
SOMAÍ Pharmaceuticals Opens Portugal Manufacturing Facility
Rapid Dose Therapeutics Enters Supplier and Purchase Agreement with a Leading Gas and Convenience Store Retailer for Nutraceutical and Vitamin Products
AR court upholds cannabis ballot measure (Newsletter: September 23, 2022)
Congressman Says Psychedelics Show ‘Real Promise’ As Alternative Therapies At Committee Hearing
Aurora Cannabis has been deleted from the S&P/TSX Composite Index
MyMD Pharmaceuticals® Provides Dosing Update on Phase 2 Multi-Center Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan
Anebulo Pharmaceuticals to Webcast R&D Day on September 26, 2022
Apple Lets Users Search For Marijuana And Pharmaceutical Interactions In Latest iPhone Health Update
Cannabis-based Sativex to be available on NHS in Scotland
Merida Capital Holdings Partners With Azucarera El Viejo for Medical Cannabis Facility in Costa Rica
Cannabis-based Sativex to be available on NHS in Scotland
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Highlights Recent Business Progress
Ramm Pharma buys Polish hemp firm from TGOD for CA$1.2 million
Legal Cannabis Sales Dip Sharply in Colorado
Legal Weed Likely To Cost Drug Companies Billions
Marijuana Moment Report: Pharmaceutical Industry Suffers Billions In Losses After States Legalize Marijuana, New Study Finds
Pharmaceutical Industry Suffers Billions In Losses After States Legalize Marijuana, New Study Finds
MyMD Pharmaceuticals Receives Grant From European Patent Office for Supera-CBD™ Compound
Karma Koala Podcast Episode 92 – Monday 29 August: June McLaughlin, Professor and Program Studies Director at Irvine Valley College, Kim Stuck Allay Consulting, Michael Sassano – Somai Pharmaceuticals & Amy McDougal -Clearesources.
UK: A blueprint for the UK Cannabis Industry
Cannabis induced psychosis: Medical cannabis much safer
Dr. Jeffrey Gudin, Chief Medical Officer of Virpax Pharmaceuticals, to Present Poster at World Congress of World Institute of Pain
DEA Chooses Seventh Cannabis Cultivator License for Research Purposes
Jazz Pharma to trial Epidyolex as treatment for Doose syndrome
Cannabis Testing Services Market by Test Type, Product Type, End-users, and Region – Global Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 – ResearchAndMarkets.com
Virpax Pharmaceuticals Reports 2022 Second Quarter Results and Recent Developments
Dravet Syndrome Treatment Market Report 2022-2029: Stiripentol and Cannabidiol to Contribute to Significant Growth of 11.7% – ResearchAndMarkets.com
A Message From Another Time & Galaxy! GW’s cannabis-derived drug Epidiolex finally launches in the US with an average list price of $32,500
Jazz's (JAZZ) Q2 Earnings Beat, New Drugs Post Robust Sales
Data Showing MyMD Pharmaceuticals’ MYMD-1® May Extend Life and Improve Health Published in the Journal of Gerontology: Biological Sciences
Flora Growth Announces Joint Venture with Colombia’s Largest Indigenous Tribe to Process and Distribute Cannabis Products
Tel Aviv Stock Exchange Eliminates TA-Cannabis Index, 4 August.Yaniv Pagot, head of trading TASE ” It’s Irrelevant”
Could CBD help Justin Beiber with Ramsey Hunt Syndrome?
Flora Growth CEO Meets With Colombian Senator as Bill to Legalize Recreational Cannabis Is Introduced
Cannabis-based drug Sativex fails latest clinical trial
Press Release: COMPASS Pathways appoints Kabir Nath as Chief Executive Officer
The Worldwide Cannabidiol Oil Industry is Projected to Reach $3.7 Billion by 2027 – ResearchAndMarkets.com
GreenLab Packaging Helps to Redefine Cannabis Packaging
MyMD Pharmaceuticals to Collaborate with Bascom Palmer Eye Institute to Study MYMD-1 in Ophthalmic Conditions
Can a new AI-powered app enhance medical cannabis treatment?
Canopy Growth Corporation v. GW Pharma Limited and GW Research Limited, Case No. 6:20-cv-01180 (W.D. Tex.)
